Selection of the most suitable test(s) for detection of Mycobacterium tuberculosis (TB) infection should be based on purpose, setting, effectiveness, and cost. Two tests are available to screen for latent TB: the tuberculin skin test (TST) and the more recent interferon-gamma release assays (IGRAs). Based on the administrative, logistic, and technical ease of use, an IGRA trial was initiated by the occupational health department at an urban Veteran's Administration health care facility for TB screening of new employees. As a result, new employees completing the pre-placement process within the organization's designated 14 days increased from 77% to 97%, new employee clearance to work time decreased from 13.18 to 5.91 days, and new employee TB screening costs were reduced by 40%. The IGRA is an acceptable alternative to the TST and has significant potential to improve the process of pre-placement TB screening.
References
1.
AdamsL. V.WaddellR. D.Von ReynF. (2008). T-SPOT.TB test results in adults with mycobacterium avium complex pulmonary disease. Scandinavian Journal of Infectious Diseases, 40, 196–203. doi: 10.1080/00365540701642179
2.
BehrmanA.BuchtaW. G.BudnickL. D.HodgsonM.RaymondL. W.RussiM.SwiftM. D. (2013). Protecting health care workers from tuberculosis, 2013. Journal of Occupational and Environmental Medicine, 55, 985–988.
3.
BienekD. R.ChangC. K. (2009). Evaluation of an interferon-gam-ma release assay, T-SPOT.TB, in a population with a low incidence of tuberculosis. International Journal of Tuberculin Lung Diseases, 13, 1416–1421.
DenkingerC.DhedaK.PaiM. (2011). Guidelines on interferon-gamma release assays for tuberculosis infection: Concordance, discordance or confusion. Clinical Microbiology and Infection, 17, 806–814.
6.
de PerioM.TsevatJ.RoselleG.KralovicS.EckmanM. (2009). Cost effectiveness of interferon-gamma release assays versus tuberculin skin tests in health care workers. Archives of Internal Medicine, 169, 179–187.
7.
DewanP. K.GrinsdaleJ.LishaS.WongE.FallstadR.KawamuraL. M. (2006). Feasibility, acceptability, and cost of tuberculosis testing by whole blood interferon assay. BMC Infectious Diseases, 6, 47.
8.
DielR.NienhausA.LangeC.SchabergT., (2006). Costoptimization of screening for latent tuberculosis in close contacts. European Respiratory Journal, 28, 35–44. doi: 10.1183/09031936.06.00011806
9.
DonabedianA. (1980). An introduction to quality assurance in health care. New York: Oxford University Press.
10.
DormanS. E.BelknapR.GravisE. A.RevesR.SchlugerN.WeinfurterP.DaleyC. (2014). Interferon gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. American Journal of Respiratory Critical Care Medicine, 189, 77–87.
11.
DosanjhD. P.HinksT. S.InnesJ. A.DeeksJ. J.PasvolG.HackforthS.LalvaniA. (2008). Improved diagnostic evaluation of suspected tuberculosis in routine practice. Annals of Internal Medicine, 148, 325–336.
12.
EralpM.ScholtesS.MartellG.WinterR.ExleyA. (2012). Screening of healthcare workers for tuberculosis: Development and validation of a new health economic model to inform practice. BMJ Open, 2. doi: 10.1136/bmjopen-2011-000630
13.
FanL.ChenZ.HaoX.HuZ.XiaoH. (2012). Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: A systematic review and meta-analysis. FEMS Immunology and Microbiology, 65, 456–466.
14.
GonzalezM.ColonH. A. (2013). Updating a tuberculosis surveillance program: Considering all the variables. Workplace Health and Safety, 61, 271–278.
15.
GordinF.MansurH. (2012). Current approaches to tuberculosis in the United States. Journal of the American Medical Association, 308, 283–289.
16.
GranG.AbmusJ.Dyrhol-RiiseA. (2013). Screening for latent tuberculosis in Norwegian health care workers: High frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results. BMC Public Health, 13, 353.
17.
GrevesonK. (2009). Can ELISpot replace the tuberculin skin test for latent tuberculosis?British Journal of Nursing, 18, 1248–1254.
18.
HerreraV.PerryS.ParsonnetJ.BanaeiN. (2011). Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clinical Infectious Diseases, 52, 1031–1037.
19.
Hirsch-MovermanY.WallK.WeinfurterP.MunkE.MoranJ. A.MaiuriA.DelucaN. (2013). Acceptability of interferon-gamma release assays among healthcare workers who receive routine employee tuberculosis testing. International Journal of Occupational and Environmental Health, 19, 319–324.
20.
JensenP.LambertL.IademarcoM.RidzonR. (2005). Guidelines for preventing the transmission of mycobacterium tuberculosis in healthcare settings. Morbidity and Mortality Weekly Reports, 54, 1–141.
21.
Joint Commission. (2011). Comprehensive accreditation manual for hospitals. Oakbrook, IL: Joint Commission Resources, Inc.
22.
KingT. (2013). The clinical and logistical advantages of the IGRAs versus the TST for at risk individuals. Bethesda, MD: CME Outfitters, LLC. Retrieved from www.cmeoutfitters.com
23.
LambertL.RajbhandaryS.QuallsN.BudnickL.CatanzaroA.CookS.RevesR. (2003). Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. Infection Control and Hospital Epidemiology, 24, 814–820.
24.
MazurekG.VernonA.LoBueP.GoldbergS.CastroK. (2010). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States 2010. MMWR, 59, 1–25.
25.
NienhausA.SchablonA.Torres-CostaJ.DielR. (2011). Systemic review of cost and cost effectiveness of different TB screening strategies. Health Service Research, 11. Retrieved from http://www.biomedcenter.com/1472-6963/11/247
26.
PetzelR. A. (2012). Undersecretary for health's information letter: Use of interferon-gamma release assays as an aid for diagnosing mycobacterium tuberculosis. Veterans Health Administration Information Letter, 1–5.
27.
Poiani DarackiL. A. (2013, May). Use of QuantiFERON-TB Gold in Tube for TB surveillance. Presented at Proceedings from the Pennsylvania Association of Occupational Health Nurses conference, Valley Forge, PA.
28.
PooranA.BoothH.MillerR. F.ScottG.BadriM.HuggettJ. F.DhedaK. (2010). Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: A cost effectiveness analysis. BMC Pulmonary Medicine, 10, 7.
29.
RamosJ. M.RobledanoC.MasiaM.BeldaS.PadillaS.RodriguezJ. C.GutierrezF. (2012). Contribution of Interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: A comparison of QuantiFERON-TB Gold in Tube, T-Spot. TB and tuberculin skin test. BMC Infectious Diseases, 12, 169.
30.
ShahM.MieleK.ChoiH.DiPietroD.Martin-EvoraM.MarsigliaV.DormanS. (2012). QuantiFERON-TB gold in-tube implementation for latent tuberculosis in a public health clinic: A cost-effectiveness analysis. BMC Infectious Diseases, 12, 360.
31.
SchultT.AwosikaE.HodgsonM.DyrenforthS. (2011). Disparities in health behaviors and chronic conditions in health care providers in the Veterans Health Administration. Journal of Occupational and Environmental Medicine, 53, 1134–1145.
32.
TrajmanA.SteffenR. E.MenziesD. (2013). Interferon-gamma release assays versus tuberculosis skin testing for the diagnosis of latent tuberculosis infection: An overview of the evidence. Pulmonary Medicine, 2013, 601737.
33.
Undersecretary for Health. (2011). Fiscal year 2011 human resources recruitment systems redesign collaborative. Washington, DC: Department of Veterans Affairs.
34.
Van Zyl-SmitR. N.ZwerlingA.DhedaK.PaiM. (2009). Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: A systemic review. PLosS One, 4, e8516.
35.
Wrighton-SmithP.SneedL.HumphreyF.TaoX.BernackiE. (2012). Screening health care workers with interferon-gamma release assay versus tuberculin skin test. Journal of Occupational and Environmental Medicine, 54, 806–815.
36.
ZwerlingA.Van den hofS.ScholtenJ.CoblelensF.MenziesD.PaiM. (2012). Interferon-gamma release assays for tuberculosis screening of healthcare workers: A systematic review. Thorax, 67, 62–70.
